These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35700069)

  • 1. Second-line immunotherapy and functional outcomes in autoimmune encephalitis: A systematic review and individual patient data meta-analysis.
    Halliday A; Duncan A; Cheung M; Boston RC; Apiwattanakul M; Camacho X; Bowden S; D'Souza W
    Epilepsia; 2022 Sep; 63(9):2214-2224. PubMed ID: 35700069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
    Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
    Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
    Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.
    Nosadini M; Eyre M; Molteni E; Thomas T; Irani SR; Dalmau J; Dale RC; Lim M; ; Anlar B; Armangue T; Benseler S; Cellucci T; Deiva K; Gallentine W; Gombolay G; Gorman MP; Hacohen Y; Jiang Y; Lim BC; Muscal E; Ndondo A; Neuteboom R; Rostásy K; Sakuma H; Sartori S; Sharma S; Tenembaum SN; Van Mater HA; Wells E; Wickstrom R; Yeshokumar AK
    JAMA Neurol; 2021 Nov; 78(11):1333-1344. PubMed ID: 34542573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disease Characteristics, Treatment, and Prognosis of Chinese Patients with Autoimmune Encephalitis: A Retrospective Study].
    Yang RN; Ge FF; Jiang JW; Wang Y; Zhang W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):142-148. PubMed ID: 35048615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics, treatments, outcome, and prognostic factors of severe autoimmune encephalitis in the intensive care unit: Standard treatment and the value of additional plasma cell-depleting escalation therapies for treatment-refractory patients.
    Schwarz L; Akbari N; Prüss H; Meisel A; Scheibe F
    Eur J Neurol; 2023 Feb; 30(2):474-489. PubMed ID: 36176208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.
    de Montmollin E; Demeret S; Brulé N; Conrad M; Dailler F; Lerolle N; Navellou JC; Schwebel C; Alves M; Cour M; Engrand N; Tonnelier JM; Maury E; Ruckly S; Picard G; Rogemond V; Magalhaes É; Sharshar T; Timsit JF; Honnorat J; Sonneville R;
    Am J Respir Crit Care Med; 2017 Feb; 195(4):491-499. PubMed ID: 27552490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.
    Thaler FS; Zimmermann L; Kammermeier S; Strippel C; Ringelstein M; Kraft A; Sühs KW; Wickel J; Geis C; Markewitz R; Urbanek C; Sommer C; Doppler K; Penner L; Lewerenz J; Rößling R; Finke C; Prüss H; Melzer N; Wandinger KP; Leypoldt F; Kümpfel T;
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34599001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influential Factors, Treatment and Prognosis of Autoimmune Encephalitis Patients With Poor Response to Short-Term First-Line Treatment.
    Liu F; Zhang B; Huang T; Wang B; Wang C; Hao M; Guo S
    Front Neurol; 2022; 13():861988. PubMed ID: 35493830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of rituximab in autoimmune encephalitis: A meta-analysis.
    Nepal G; Shing YK; Yadav JK; Rehrig JH; Ojha R; Huang DY; Gajurel BP
    Acta Neurol Scand; 2020 Nov; 142(5):449-459. PubMed ID: 32484900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune therapy in autoimmune encephalitis: a systematic review.
    Nosadini M; Mohammad SS; Ramanathan S; Brilot F; Dale RC
    Expert Rev Neurother; 2015; 15(12):1391-419. PubMed ID: 26559389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan.
    Kong SS; Chen YJ; Su IC; Lin JJ; Chou IJ; Chou ML; Hung PC; Hsieh MY; Wang YS; Chou CC; Wang HS; Lin KL;
    Pediatr Neonatol; 2019 Aug; 60(4):417-422. PubMed ID: 30449706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune characteristics of children with autoimmune encephalitis and the correlation with a short-term prognosis.
    Huang JY; Fan WX; Meng J; Cai CQ; Li D
    Ital J Pediatr; 2022 Jun; 48(1):94. PubMed ID: 35698204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
    Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of autoimmune encephalitis secondary to epidemic encephalitis B in 5 children].
    Song LF; Wang L; Tang ZH; Xian YX; Liu K; Ma YN
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):302-307. PubMed ID: 36946167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal rank of clinical characteristics and prognosis of anti-N-methyl-d-aspartate receptor encephalitis.
    Yang R; Ge F; Jiang J; Wang Y; Wan M; Zhang W
    Brain Behav; 2021 Aug; 11(8):e2277. PubMed ID: 34232562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of anti
    Zheng J; Shen J; Wang A; Liu L; Xiong J; Li X; Xiao Y; Li J; Mao D; Liu L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 45(1):47-54. PubMed ID: 32132297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study.
    Lee WJ; Lee ST; Moon J; Sunwoo JS; Byun JI; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Kim S; Park KI; Jung KH; Jung KY; Kim M; Lee SK; Chu K
    Neurotherapeutics; 2016 Oct; 13(4):824-832. PubMed ID: 27215218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis.
    Wu Q; Xie Q; Liu L; Meng C; Wang J
    Mult Scler Relat Disord; 2023 Jun; 74():104697. PubMed ID: 37031550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
    Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D
    Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.